FP7 Marie Curie Initial Training Network (ITN)
FightingDrugFailure (Grant Agreement Number 238132)
Marie Curie Research Training Networks, an initiative of the Commission of the European Communities, provide training and research experiences for researchers at the beginning of their careers by giving them the opportunity to spend up to two years in another country as part of an international, high-quality research project. These training networks contribute to knowledge transfer through the promotion of multidisciplinary research and the interaction of researchers on all levels working within the project.
Pharmacogenetics is the scientific discipline that relates inter-individual variation in drug response and efficacy to genetic variation. While there have been major advances in basic genomic knowledge and genotyping technologies, translation into practice has been slow. It is essential we quicken the pace of translational research in pharmacogenomics – at present, we are only just beginning to be able to define which patients are going to respond to drugs, and which patients are going to develop adverse drug reactions.
Priorities and Standards in Pharmacogenomic Standards:
Opportunities for a Safer and More Efficient Pharmacotherapy
In this ITN, our concerted action across the EU, associated countries and an international co-operation partner country in collaboration with US researchers, will train young investigators and clinicians in the principles and scientific basis of Pharmacogenomics in order to establish, evaluate and retrieve relevant genetic information from patients and relate it to clinical outcomes of drug therapy. This will be achieved through sharing patient materials, performing pooled analyses, transferring knowledge and skills across laboratories and utilizing access to high-throughput technology platforms among 5 academic institutions and 3 industry partners. This will enhance translational research, promote uniform drug treatment standards throughout Europe and, ultimately, the world, and improve the competitiveness of the EU in this emerging and exciting new field.
We are currently seeking applications for
1 Postdoctoral Researcher / 1 Experienced Researcher (ER)
in Pharmacogenomics. This 2-year mobility program, based at the Institute of Clinical Pharmacology (IKP) in Stuttgart, Germany, will provide an eligible international researcher with in-depth-training in breast cancer susceptibility and pharmacogenomics as well as international experiences at both academic and industry partners. Short-term visits to partner facilities will provide the researcher with network-wide training, including interdisciplinary and intersectional transfer of knowledge and new techniques. The Experienced Researcher will participate in the collaboration with international breast cancer research networks.
Experienced Researcher (ER) - researcher who is either in possession of a doctoral degree or has at least four years full-time equivalent research experience.
We offer
- Postdoctoral / experienced researcher position based in Stuttgart, Germany, in the cutting-edge field of Pharmacogenomic Curriculum (1st in Europe)
- Individualized research and training plans encompassing both academic and industry settings tailored to the specific ER’s educational needs
- Working contracts with benefits adjusted to living conditions according to EU guidelines
- International placements with relocation assistance
- Start Date: September 2011
- Career development counseling throughout the entire program
Successful applicants
- possess an internationally recognized life science degree (PhD preferred)
- or 4 years pharmacogenomics-related research experience
- have less than five years total research experience within their research careers
- posses a relevant first degree (ie. molecular biology, clinical pharmacology, etc) which is internationally recognized
- are able to perform association studies, including relevant statistical analysis
- have laboratory experience in a molecular biology setting
- desire to train within a mobility program throughout Europe, associated countries and an international cooperation partner country and are willing to relocate to Stuttgart, Germany for the duration of the position
- are highly motivated and able to work both independently and as part of an interdisciplinary international team
- possess proficiency in the English language
Preference will be given to candidates with experience in any of the following:
Cell Biology, Chemical Analytics, Molecular Epidemiology, High Through-Put Genotyping, Assoication Analysis, Isolation of Nucleic Acids from Human Materials, Clinical Data Acquisition, Statistical Programs including SAS & R-Package
Qualified applicants should direct a Curriculum Vitae with Cover Letter, Two Letters of Recommendation with contact email addresses and a List of Further Qualifications preferably via email to either the ITN Project Coordinator.
ITN Project Coordinator
IKP Stuttgart
Auerbach Str. 112
70367 Stuttgart
Germany
A detailed description of the ITN as well as the participating Partner Sites can be found on our website www.fightingdrugfailure.net. All applications must be received by August 1, 2011.